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The Role of Serratia marcescens Porins 
in Antibiotic Resistance
NEUS RUIZ,1 TERESA MONTERO,2 JORDI HERNANDEZ-BORRELL,2 and MIQUEL VIÑAS1
ABSTRACT
The outer membrane permeability of Serratia marcescens was studied by comparing porin-deficient mutants
with their parental strains. Omp1-deficient strains were selected by moxalactam resistance, whereas mutants
lacking the Omp2 porin were obtained by experimental infection with the SMP2 phage, whose primary re-
ceptor is the Omp2 porin. The role of porins was demonstrated in quinolone accumulation assays, where semi-
quantitative differences in accumulation were observed. Permeability coefficients to cephaloridine of Omp1
mutants were determined and compared with those of the parental strain. The clinical isolates S. marcescens
HCPR1 and 866 showed 30- to 200-fold reduced permeability coefficients when Omp1 porin was absent.
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INTRODUCTION
SERRATIA MARCESCENS produces a wide range of opportunis-tic infections and nosocomial outbreaks. In the last 15 years,
the consistent resistance of Serratia clinical isolates to many
antimicrobial agents has been documented.6,9,24,29 Multiresis-
tance is often plasmid encoded, and the combined action of
plasmids and the species-specific intrinsic resistance of S.
marcescens makes this microorganism difficult to control.
The characteristic resistance of Gram-negative bacteria is
due to the outer membrane barrier, which acts as a coarse sieve
that excludes (or limits the uptake of) many of the noxious mol-
ecules present in the external medium. The outer membrane is
formed by lipid bilayer regions, consisting of either proteins,
phospholipids, or lipopolysaccharide (LPS) molecules, which
show unusually low permeability toward hydrophobic solutes.
Some of the outer membrane proteins (OMPs), porins, form
channels that often exclude hydrophilic compounds according
to their exclusion limit.
Porins have been described as b-sheet channel-forming pro-
teins in the outer membrane of Gram-negative bacteria, mito-
chondria, and chloroplasts. The transmembrane pores produced
by these proteins are formed from amphipathic b-strands
arranged in a barrel configuration.26 Many of these porins are
either nonspecific, such as OmpF or OmpC, or only moderately
selective, such as PhoE in Escherichia coli. Their combined to-
tal number present in the membrane remains constant, while
the amount of each one varies according to various external fac-
tors.17
In 1990, Malouin13 reported the presence of a single porin
of S. marcescens (clinical strain UOC69) with a molecular mass
of 41 kDa. Puig,23 2 years later, published an electrophoretic
study of the outer membrane porins of Serratia. In this study,
three different porins were described and named Omp1, Omp2,
and Omp3, with molecular masses of 42, 40, and 39 kDa, re-
spectively. These porins showed similar osmoregulation and
thermoregulation as OmpC and OmpF of E. coli. Later, Hutsul
and Worobec8 described this behavior in two porins from Ser-
ratia, which they called OmpF and OmpC.
In this report, we examine the physiological role of Omp1
and Omp2 porins in allowing the diffusion of nutrients, anti-
biotics, or inhibitors across the outer membrane by comparing
porin-deficient mutants with their isogenic wild-type strains.
MATERIALS AND METHODS
Media and chemicals
Trypticase soy broth (TSB), trypticase soy agar (TSA), nu-
trient broth (NB), and Mueller Hinton (MH) broth were pur-
chased from Scharlau (Barcelona, Spain). The disk antibiotics
were purchased from OXOID, and ciprofloxacin was kindly
supplied by CENAVISA Laboratories (Reus, Spain).
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Microbial strains
S. marcescens NR1 strain22 is an O-side LPS-deficient (de-
rived from NIMA) and was used for the enrichment bacterio-
phage experiments. S. marcescens HCPR1m100 and 866m100
are spontaneous mutants derived from HCPR1 and 866, re-
spectively. These mutants were obtained by serial selection in
media containing increasing concentrations (up to 100 mg/ml)
of moxalactam Sigma-Aldrich (St. Louis, MO). S. marcescens
NIMA 12 was obtained from NIMA by culturing the bacterium
in the presence of SMP2 phage and picking colonies grown in-
side the inhibition zones.
Antibiotic susceptibility test
Minimal inhibitory concentrations (MIC) were also deter-
mined by the broth dilution method. Overnight cultures of the
bacterial strain in MH broth were diluted 1,000-fold in fresh
broth, and 5 ml of the bacterial suspension (0.5 3 104 cfu/ml
approximately) was inoculated into MH broth containing ser-
ial dilutions of the antimicrobial agents. MICs were determined
after 18 hr of incubation at 37°C as the minimum concentra-
tion of antibiotic that inhibits growth.
Outer membrane preparations and sodium dodecyl
sulfate-polyacrylamide gel electrophoresis
LPS and OMPs were obtained as described by Hitchcock7
and a modification of Filip,4 respectively. To detect OMP frac-
tions, SDS-PAGE was performed using a modification of the
method of Laemmli11,23; gels were stained with 0.25%
Coomassie Brilliant Blue, and destained and dried, using Bio-
Rad apparatus (miniprotean II) for electrophoresis and a gel
dryer (Biorad 543). OMPs were compared with a size standard
marker purchased by Biorad (USA). LPS gels were silver
stained using a modification of the Tsai and Frash method.32
The degree of similarity between electrophoregrams was esti-
mated by visual comparison of the stained gels.
Bacteriophage experiments
Bacteriophage susceptibility was determined by the spot
method using TSA medium. Conventional methods were used
for phage isolation, propagation, and purification.25
In adsorption experiments, 103 phage were incubated at 30°C
for 15 min with 100 mg of different bacterial fractions: (1) LPS,
isolated and purified by a modification of the Osborn’s proce-
dure31; (2) outer membrane solubilized by sodium lauryl sar-
cosinate (0.5% wt/vol); (3) outer membrane treated with phe-
nol at 70°C (LPS will be removed); and (4) outer membrane
treated with proteinase K. Afterwards, chloroform was added
and the samples were centrifuged at 11,000 3 g for 10 min to
separate the nonadsorbed phage. Quantification of these phages
were purchased using S. marcescens NR1 as a host strain.
Bacteriophage purification and visualization
Phage stocks for electron microscopy were prepared using
the method described in Sambrook.27 Briefly, phages were con-
centrated by the polyethylene glycol method and then, cen-
trifuged in a CsCl gradient before being dialyzed against sev-
eral changes of phosphate buffer. A drop of phage suspension
was placed on formvar carbon-coated copper grids and stained
with a drop of 2% (wt/vol) uranyl acetate, the excess moisture
being removed with filter paper. Negatively stained virions
were observed using a Hitachi H800 MT transmission electron
microscope.
Quinolone accumulation
Quinolone accumulation was measured as described by Mor-
timer and Piddock15 with some modifications. Isolates were in-
cubated at 37°C until A600nm 5 0.5–0.7. Bacteria were har-
vested by centrifugation (9,000 3 g) at room temperature, and
washed and concentrated 10-fold in phosphate-buffered saline
(PBS) pH 7.5. At this pH, maximal proportions of both un-
charged and zwitterion quinolones were present (data not
shown). Quinolone used in these experiments was
ciprofloxacin, and it was added to 1-ml aliquots up to a final
concentration of 10 mg/ml. At 0.25, 0.5, 1.5, 3, 6, 8, 10, 15,
and 20 min, samples were centrifuged at 9,000 3 g at 4°C for
1 min. Pellets were resuspended in 1 ml of 0.1 M glycine-HCl
buffer pH 3.0, and finally incubated at room temperature
overnight to allow bacterial lysis. Suspensions were then cen-
trifuged at room temperature for 25 min to remove bacterial de-
bris. Antibiotic concentration in supernatants was determined
spectrofluorometrically using an SLM Aminco 8100 spectro-
fluorometer.
b-Lactamase kinetic parameters and outer 
membrane permeability
Diffusion rates of b-lactams through the outer membrane of
intact cells were determined following the method of Zimmer-
mann and Rosselet,33 as modified by Nikaido.16 Briefly, strains
were grown in NB, supplemented with 5 mM MgSO4 and 6-
aminopenicillanic acid as a b-lactamase inducer (50 mg/ml) at
37°C with shaking.
Intact cells (100 mg/ml) were added to an assay medium con-
taining 10 mM sodium phosphate buffer pH 7, 5 mM MgCl2,
and five different antibiotic concentrations of cephaloridine
(0.1, 0.2, 0.4, 0.8, and 1.6 mM). The suspension was then mixed
and rapidly transferred to a cuvette with a 1-mm light path, and
the decrease in absorbance at 260 nm was recorded in a UNI-
CAM UV/NIM spectrophotometer. Assays were performed at
25°C, and the diffusion rates of b-lactam across the outer mem-
brane were calculated according to the method of Zimmermann
and Rosselet.33
A portion of the cell suspension (100 mg/ml) was sonicated
using a Branson sonicator for three periods of 1 min each in an
ice bath, and the sonic extract was used for the determination
of enzyme kinetics parameters (vmax and Km). The Michaelis-
Menten constant (Km) was obtained from a Lineweaver-Burke
plot drawn with the results of independent experiments with
five different antibiotic concentrations (0.1, 0.2, 0.4, 0.8, and
1.6 mM). So as to refer to protein concentration instead of dry
weight, we modified the v0 equation proposed by Nikaido.19
Finally, vmax values were obtained from the Michaelis-Menten
equation.
To determine enzyme kinetics, cultures were prepared as de-
scribed above and lysed by ultrasonic treatment using a Bran-
son sonicator for three periods of 1 min each in an ice bath.
The Michaelis-Menten constant (Km) was obtained from a
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Lineweaver-Burke plot drawn with the results of independent
experiments with five different antibiotic concentrations (0.1,
0.2, 0.4, 0.8, and 1.6 mM). So as to refer to protein concentra-
tion instead of dry weight, we modified the v0 equation pro-
posed by Nikaido.19 Finally, vmax values were obtained from
the Michaelis-Menten equation.
Permeability coefficients (P) were calculated from Fick’s
first law. The cell-surface area, calculated from electron mi-
croscopy data, was approximately 3.3 mm2/cell. Transforming
this value of protein, an area of 0.355 cm2/mg of protein was
obtained. Final values of P coefficients were calculated, taking
into account the values of extracellular enzymatic activity (en-
zyme leakage). The hydrolysis rates of intact cells were cor-
rected for the contribution of extracellular enzyme, but this cor-
rection amounted to less than 0.5% of the intact cell rates. In
S. marcescens, the ratio between volume and area (V/A) was
0.15 mm. From this, and the P values, we calculated the semi-
equilibrium period (T1/2) as (1/P) ? ln 2 ? (V/A).
RESULTS
Selection of moxalactam-resistant mutants from 
S. marcescens
Komatsu10 studied the alterations in outer membrane pro-
teins in E. coli by selection of moxalactam-resistant mutants,
which showed the permeability of the outer membrane affected.
Two clinical isolates of Serratia were chosen to obtain mox-
alactam-resistant mutants. The HCPR1 strain was resistant to
most of the antibiotics tested, including some quinolones, sul-
fonamides, aminoglycosides, and b-lactams. Conversely, S.
marcescens 866 was susceptible to these antibiotics.
Moxalactam was used as a selective agent because it has a
broader spectrum of antibacterial activity than do previously
tested cephalosporins; this may be due to its resistance to a
wide variety of b-lactamases, its better penetration into the
cell, or its easier attachment to target proteins. Spontaneous
moxalactam-resistant mutants were isolated at a frequency of
1026 to 1027. The mutants were selected by spreading aliquots
from overnight cultures of each strain on TSA plates con-
taining increasing concentrations of moxalactam and incubat-
ing them at 37°C. One colony was picked from each plate and
purified by repeated streaking on TSA with antibiotic. Figure
1 shows the outer membrane electrophoretic profiles of mox-
alactam-resistant mutants and their parental strains. In both
cases, there was a lack of porin in the profiles that corre-
sponded to Omp1.
Outer membrane electrophoretic profiles displayed two ma-
jor porins (Omp1 and Omp2) regulated in different osmolarity
environments. Omp1 was expressed normally at a constitutive
level and was overexpressed under low-osmolarity conditions,
whereas Omp2 was overexpressed under high-osmolarity con-
ditions.23 This response to osmotic conditions is similar to what
is seen in OmpF and OmpC porins of E. coli, the former ex-
pressed at an increased level under low-osmolarity conditions.
It is well known that in E. coli OmpF produces a pore diame-
ter larger than that of OmpC (1.2 nm and 1.1 nm, respectively)17
and antibiotic resistance due to decreased outer membrane per-
meability is observed in OmpF-deficient mutants.20 Similarly,
a relationship between the pore diameter of Omp1 and mox-
alactam-resistant phenotypes can be assumed.
Bacteriophage isolation and characterization of their
primary receptor
Although most phages active on Gram-negative bacteria
have their primary receptor in the LPS,14 some phages adsorb-
ing on OMPs have also been described.2 To obtain porin-defi-
cient mutants, we searched for bacteriophages in highly pol-
luted rivers in the region around Barcelona. These phages were
enriched on an O-side-defective mutant (NR1)21 to favor se-
lection of phages having an OMP as the primary receptor.
Absorption experiments showed that the SMP2 phage binds
to OMPs. Solubilized outer membrane from S. marcescens NR1
or NIMA inactivated phage suspensions, indicating that the
SMP2 phage receptor is an outer membrane component. The re-
sults showed clear differences between proteinase K-untreated
and -treated outer membrane, indicating once again that the re-
ceptor was an OMP. These results were corroborated by the se-
lection of bacterial strains resistant to the SMP2 phage and the
subsequent OMP and LPS electrophoretic profiles analyses. Fig-
ure 2 shows a dramatic decrease in, or even absence of, OMP2
in phage-resistant mutants when compared with the parental
strain in a SDS-PAGE gel. From these mutants, we selected S.
marcescens NIMA-12 for further experiments due to the com-
pletely undetectable Omp2 band in this strain. LPS elec-
trophoretic profiles of either NIMA and the porin-deficient mu-
tant NIMA-12 were identical, whereas the NR1 strain completely
lacks the O-side chain. These results strongly suggested that
Omp2 is the primary receptor of phage SMP2.
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FIG. 1. SDS-PAGE of outer membrane of HCPR1 (lane a),
866 (lane c), and their moxalactam-resistant mutants: HCPR1
m100 (lane b) and 866 m100 (lane d). Omp1 porin is absent
from mutant strains.
Electron microscopy (Fig. 3) showed that the SMP2 bacte-
riophage had an isometric head of 130 nm in diameter and tails
190 nm long and 25 nm wide. Moreover, the SMP2 phage pre-
sents a base plate with two spikes. A schematic diagram of
SMP2 virions is also shown in Fig. 3.
Antimicrobial susceptibility and permeability studies of
porin-deficient mutants by accumulation of quinolone
Table 1 summarizes the results of the antibiotic susceptibil-
ity of porin-deficient mutants and their parental strains, which
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FIG. 2. (Left) SDS-PAGE of outer membrane of NIMA (lane a), NR1 (lane b), and their OMP2-deficient mutants: NIMA-3
(lane c), NIMA-9 (lane d), and NIMA-12 (lane e). Omp2 porin is absent from mutant strains. (Right) SDS-PAGE of lipopolysac-
charide of NR1 (lane a), a mutant strain NIMA-12 (lane b), and NIMA (lane c). No significant differences were observed be-
tween mutant strain and its parental.
FIG. 3. (Left) Electron micrograph of SPM2 virion. Bar represents 100 nm. (Right) Schematic diagram of a virion SMP2.
were assessed by determination of minimal inhibitory concen-
trations (MICs). In E. coli, most b-lactam, and other small hy-
drophilic agents such as chloramphenicol, tetracyclines, and
aminoglycosides predominantly use the porin pathway.20 The
mutants lacking the Omp1 porin (S. marcescens HCPR1 m100
and 866 m100) showed a high degree of resistance toward sev-
eral antimicrobial agents, and these differences were about 10-
to 130-fold higher than in parental strains (S. marcescens
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TABLE 1. MICS (mG/ML) OF DIFFERENT ANTIMICROBIAL AGENTS TO S. MARCESCENS
Porin-deficient mutants of S. marcescens
Antibiotic HCPR1 HCPR1-m100 866 866-m100 NIMA NR1 NIMA-12
Cefoxitin 125 1000 62.5 500 15.6 31.2 31.2
Ceftriaxone 2 250 0.5 31.5 0.5 0.5 4
Cefotaxime 4 250 0.5 62.5 0.5 0.5 2
Moxalactam 15.6 2000 31.2 2000 8 31.2 31.2
Ciprofloxacin 1.6 3.1 0.1 0.8 0.1 0.2 0.1
Tetracycline 125 125 8 15.6 15.6 31.2 31.2
Chloramphenicol 15.6 31.5 15.6 31.5 15.6 31.2 31.2
FIG. 4. Ciprofloxacin accumulation. (Top) NIMA, NR1, and NIMA12. (Bottom) Moxalactam-resistant mutants and their
parental strains: HCPR1, HCPR1m100, 866, and 866m100. 
HCPR1 and 866, respectively). In contrast, the Omp2-deficient
mutant gave susceptibility values close to those determined in
NIMA. This finding supports the idea that the Omp1 is the main
way for antibiotic penetration into the bacteria.
Ciprofloxacin accumulation is shown in Fig. 4, showing a
significant reduction in 866 m100, NR1, and NIMA 12, and a
two-fold reduction in HCPR1 m100. However these differences
in accumulation have a poor reflect in MIC values.
Studies of permeability to b-lactam in 
Omp1-deficient strains
A method for measuring outer membrane permeability of b-
lactam antibiotic, developed separately by Zimmermann and
Rosselet and Sawai,30,33 was used to demonstrate that porin-
deficient mutants have 10- to 100-fold-lower rates of b-lactam
permeation than do their porin sufficient parental strains. We
selected Omp1-deficient strains to study the properties of this
channel, which clearly seems to be involved in the intrinsic re-
sistance to antibiotics. All strains tested showed that b-lacta-
mase activity corresponded to a chromosomally encoded b-lac-
tamase type C.12
Table 2 shows the kinetic parameters of Serratia b-lacta-
mase. The affinity of S. marcescens b-lactamase for cephalori-
dine is relatively low, especially when compared with the affini-
ties detected in other Gram-negative bacteria.18 This affinity
was lower in mutants lacking the Omp1 porin. An overpro-
duction of b-lactamase could explain the higher values of Vmax.
Table 2 also shows the P and T1/2 values. P coefficients can
be regarded as closer values to E coli K12, estimated as 5 ?
1024 cm/s in the case of the 866 strain and lower in the HCPR1
strain. The P coefficient was reduced 30-fold and 30- to 100-
fold in HCPR1 m100 and 866 m100 mutants, respectively.
It was also determined the value of the target access index
(TAI) determination,19 which reflects the probability of b-lac-
tam molecules, in our case cephaloridine, reaching the target
(penicillin-binding proteins). TAI could be divided in two equa-
tions that allow assessment of the relative importance of the
outer membrane (Aiom) and the b-lactamase (Aiperi) in the an-
tibiotic resistance. Table 3 shows the values for each strain stud-
ied and reflects the role of the outer membrane in the intrinsic
resistance to antimicrobial agents.
DISCUSSION
It is well known that the outer membrane plays a major role
in the biology of Gram-negative bacteria, because it acts as an
effective barrier to many solutes and, consequently, antibiotics
such as macrolide, novobiocin, rifampin, clindamycin, or fu-
sidic acid. Analysis of antimicrobial susceptibility of clinical
and environmental strains of S. marcescens demonstrates that
the levels of resistance to antimicrobial agents of Serratia are
much higher than those of any other species of Enterobacteri-
aceae, such as E. coli or Klebsiella.5
Moreover, clinical isolates are nonpigmented and, in general,
more resistant than environmental and pigmented strains. Some
authors have proposed a clonal structure of clinical populations.
A positive co-relationship between the inability to produce pig-
ment and the ability to accept plasmids, which can make bac-
teria multiresistant, has been also suggested.3 In the present
study, we used several clinical isolates, among which, HCPR-
1 showed a highly particular susceptibility profile. HCPR-1 was
resistant to some aminoglucosides, sulfonamides, or quinolones
which were active on the other isolates.
To elucidate the role of outer membrane permeability in Ser-
ratia antibiotics resistance, we focused our attention on the role
of porins in penetration by antibiotics. A porin loss or a de-
creased expression of porin is an important cause of resistance
N. RUIZ ET AL.262
TABLE 2. KINETICS PARAMETER OF b-LACTAMASE, COEFFICIENT PERMEABILITY (P), AND
SEMIEQUILIBRIUM TIME (T) OF S. MARCESCENS STRAINS TO CEPHALORIDINE
Km vmax P T1/2
Strain (mM) (nmols ? s21 ? mg prot21) ra (cm ? s21) (s)
HCPR1 580 0.0140 6 0.0017 0.984 2.80 ? 1025 0.371
HCPR1 m100 1300 0.075 6 0.008 0.989 9.00 ? 1027 11.60
866 510 0.004 6 0.007 0.983 6.79 ? 1024 0.015
866 m100 800 0.052 6 0.008 0.982 2.20 ? 1026 4.73
aLineal correlation coefficient.
TABLE 3. MICS OF CEPHALORIDINE FOR FOUR STRAINS STUDIED AND VALUES OF TAI AND ITS TWO COMPONENTS, 
ACCESS INDEX PERIPLASMIC (AIPERI) AND OUTER MEMBRANE CONTROLLED (AIOM)
MIC
Strain TAI AIom AIperi (mg/ml)
HCPR1 0.4151 0.4420 0.9389 20.51
HCPR1 m100 0.0057 0.0142 0.4028 1057.07
866 29.1656 0.1070 2.7200 6.22
866 m100 0.0121 0.0347 0.3481 503.56
to some antibiotics, particularly b-lactams, chloramphenicol,
tetracyclines, and some quinolones. We obtained two kinds of
mutants deficient in porin expression using two different
methodologies: (1) to obtain strains lacking the Omp1 porin,
we selected moxalactam-resistant mutants; and (2) to obtain
Omp2-deficient mutants, we isolated and studied a bacterio-
phage whose primary receptor was this porin (SMP2), and we
then selected mutants by their resistance to the SMP2 phage.
One of each type of mutant was selected for further experi-
ments.
The ease in obtaining Omp1-deficient mutants on media con-
taining moxalactam by selection is due to the fact that Omp1
produces larger pores than does Omp2, similar to those of
OmpF and OmpC in E. coli.20 Therefore, it is possible that
Omp1 is the pathway by which moxalactam penetrates cells. It
should be noted that in S. marcescens the molecular weight of
the larger-channel-forming protein (Omp1) is higher than that
of Omp2, which produces narrow channels. It could be hy-
pothesized that the loss of Omp1 has dramatic effects on an-
tibiotic susceptibility because Omp2 narrow channels seem to
allow the entry of most nutrients but only a few antibiotics. The
great differences in size between colonies formed by mutants
(small) and their parental strains (normal in size) seem to sup-
port this hypothesis.
We demonstrate that the primary receptor of SMP2 was the
Omp2 porin. Adsorption experiments showed that the SMP2
phage primary receptor was an outer membrane protein. The
selection of mutants resistant to this phage (lacking Omp2 in
SDS-PAGE) confirmed that Omp2 is the SMP2 bacteriophage
receptor.
The role of porins in vivo with respect to the permeation of
substrates across the outer membrane of this was done by means
of fluorometric experiments using quinolone accumulation as
well as by determining b-lactam permeabilities. Preliminary
analysis (Table 2) showed that Omp1-deficient mutants were
much more resistant than mutants lacking Omp2.
We studied ciprofloxacin accumulation and, as can be seen
in Fig. 4, there were great differences between porin-deficient
strains and their parental ones. The loss of a porin in all porin-
deficient mutants could affect quinolone entry and may lead to
decreased intracellular accumulation. It was not feasible to com-
pare the two mutants because they had different origins: The
Omp1-mutants were selected from two clinical isolates (HCPR-
1 and 866) whereas the mutant lacking Omp2 came from an
environmental strain (NIMA). Moreover, phage SMP2 was un-
able to accomplish a lytic cycle on the clinical isolates.
Differences in ciprofloxacin accumulation have not a clear
reflect on their MIC values. Ciprofloxacin is a fluoroquinolone
that uses three different methods to penetrate the bacteria: (1)
a hydrophobic way throughout the lipid bilayer; (2) a self-
promoted entry, which has been interpreted as a movement 
of the divalent cations that join closer molecules of the LPS
and change the structure of the outer membrane; and (3) a hy-
drophilic way due to the channel-forming activity of porins. Al-
though the estimation of the MIC values did not show clear dif-
ferences between mutants and wild-type bacteria, accumulation
of ciprofloxacin by fluorometric experiments suggested that
ciprofloxacin uses mainly Omp1 protein to penetrate the Ser-
ratia outer membrane. Furthermore, it should be noted that MIC
values are the minimal concentration of the antibiotic that pre-
vents the division of the cell during incubation as long as 18
hr. During this period, ciprofloxacin can penetrate into the bac-
teria using one or more of the three methods cited above.
The appearance of high resistance to b-lactamic antibiotics has
been recognized as being the result of a concerted interplay be-
tween different factors, such as the enzymatic inactivation of the
antibiotic by the b-lactamase present in the bacterial periplasm,
the alteration of the target (PBPs), the efflux of the antibiotic, or
the reduced penetration into the bacteria due to the permeability
barrier of the outer membrane. In terms of the last factor, we an-
alyzed the permeability of cephaloridine through the outer mem-
brane using the method of Zimmermann and Rosselet. b-Lacta-
mase activity corresponded to a chromosomally encoded
b-lactamase. The results showed a low affinity of Serratia b-lac-
tamase for the substrate (cephaloridine) and illustrate once again
that S. marcescens presents a low affinity toward cephalosporins
in comparison with E. coli, which presents values of Km 5 230
mM for cephaloridine.19 Comparing wild-type with mutants, we
were also able to observe a decreased affinity concomitant with
an increased rate of hydrolysis in porin-deficient mutants. It is im-
portant to note that decreased outer membrane permeability of
mutant strains is not by itself enough to produce significant in-
creases to antibiotic resistance; in other words, overexpression of
b-lactamase should act in a synergistic way with the restrictions
in outer membrane permeability. In fact, Omp1 mutants were ob-
tained by serial cultivation on moxalactam-containing medium,
and all experimental results suggested the occurrence of at least
two changes: one affecting Omp1 expression and the other in-
volving b-lactamase expression. Subsequently, enzymatic differ-
ences were taken into account to elucidate separately the actual
role of the porin in antibiotic resistance in both parental and mu-
tant strains.
The permeability coefficient (P) of 866 outer membrane is
similar in value to that of E. coli.20 In any case, it is an inter-
mediate value between the low permeability of Pseudomonas
aeruginosa and the higher permeability of Haemophilus in-
fluenzae.28 In contrast, the P coefficient of the HCPR-1 strain
was lower than E. coli, and this could explain, at least in part,
the high resistance of this strain to a wide variety of hydrophilic
antibiotics. As we expected, porin-deficient strains showed, de-
creased P coefficients, the coefficients of 866 being 200-fold
those of 866-m100.
In conclusion, resistance to small hydrophilic compounds that
use water-filled channels to cross the outer membrane in S.
marcescens was increased in porin-deficient mutants. Omp1
seems to be the main pathway for ciprofloxacin entrance. Good
levels of resistance to hydrophilic antimicrobial agents were
reached when bacteria presented a decrease in OMPs. However,
in all cases, resistant strains herein reported exhibited changes
either in porins and b-lactamase expression, suggesting that re-
sistance should be seen as the result of synergistic effects of dif-
ferent mechanisms to avoid the action of the drugs. Thus, it seems
likely that porins act synergistically with enzymes and eventu-
ally with efflux systems and perhaps other specific mechanisms.
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